WealthTrust Axiom’s Pulse Biosciences PLSE Stock Holding History

WealthTrust Axiom’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$596K	Hold	21,500	–	–	0.13%	141
2026 Q1	$464K	Hold	21,500	–	–	0.11%	151
2025 Q4	$295K	Hold	21,500	–	–	0.08%	197
2025 Q3	$381K	Hold	21,500	–	–	0.1%	168
2025 Q2	$324K	Hold	21,500	–	–	0.1%	174
2025 Q1	$346K	Hold	21,500	–	–	0.11%	173
2024 Q4	$374K	Hold	21,500	–	–	0.11%	170
2024 Q3	$377K	Hold	21,500	–	–	0.11%	166
2024 Q2	$241K	Hold	21,500	–	–	0.08%	200
2024 Q1	$187K	Hold	21,500	–	–	0.06%	232
2023 Q4	$263K	Hold	21,500	–	–	0.09%	191
2023 Q3	$86.6K	Hold	21,500	–	–	0.03%	225
2023 Q2	$155K	Hold	21,500	–	–	0.05%	227
2023 Q1	$72.2K	Hold	21,500	–	–	0.02%	231
2022 Q4	$59.6K	Buy	+21,500	New	+$48.3K	0.02%	230

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WealthTrust Axiom's PLSE Position: Q2 2026 in Review

WealthTrust Axiom held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 21,500 shares worth $596K. The position accounts for 0.13% of the portfolio, ranked #141.

WealthTrust Axiom first reported a position in PLSE in Q4 2022 and has held it in 15 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

WealthTrust Axiom held 21,500 shares of Pulse Biosciences worth $596K as of Q2 2026.
WealthTrust Axiom left its Pulse Biosciences share count unchanged in Q2 2026.
Pulse Biosciences made up 0.13% of WealthTrust Axiom's portfolio in Q2 2026, its #141 holding.
WealthTrust Axiom first reported a position in Pulse Biosciences in Q4 2022 and has held it in 15 quarters since.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on WealthTrust Axiom's 13F filing for Q2 2026, filed 11 Aug 2026.